Tag Archives: EU

August, 2017

June, 2016

May, 2015

  • 8 May

    Novartis’ Zykadia Receives EU Approval for Treatment of Lung Cancer

    Novartis’ lung cancer drug gained European approval for treatment of patients with non-small cell lung cancer (NSCLC). The company said that the European Commission (EC) has approved Zykadia (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced NSCLC previously treated with crizotinib. The European Union’s (EU) approval of …